APBI:
Accelerated
Partial Breast Irradiation
APBI is a new way to give radiation therapy to the breast after a
lumpectomy, a way that is much faster and treats less of the breast
and less of the body.
Radiation
therapy is almost always recommended after a lumpectomy for breast
cancer. Typically it
takes 6 to 7 weeks, and treats the entire breast along with some underlying
ribs, muscles, a crescent of lung, sometimes a bit of heart, and all
the skin on the breast. It is effective and safe with a proven track
record, but it makes you wonder "is all this necessary for a little
tumor?". The
photo
on
the
right shows standard radiation therapy, which enters the body via two
beams, and all the area in red is treated to a high dose.
APBI does not treat the entire breast. It focuses on the part of
the breast where the tumor was removed. This allows a smaller region
to be radiated, which in turn results in less radiation to the
lung, heart, ribs, muscles, and skin. It also allows the treatment
to be given in a more condensed, faster schedule.
APBI can be given with either brachytherapy (radioactive sources in
the breast) or with external radiation beam techniques. At our clinic,
we have been using brachytherapy for breast cancer since 1997, and
have a long experience.
External
Beam APBI
We use tomotherapy in 10 treatments over 5 days. This is a nice treatment
which can be valuable when someone is not a good candidate for brachytherapy
or doesn't want to have that procedure. Brachytherapy is usually
more targeted than external beam radiation for APBI. .
Brachytherapy APBI
There are two common methods for doing breast
brachytherapy: 1) placing
multiple catheters into the breast which surround the area where the
tumor used to be, or 2) placing a single catheter in the breast which
contains a balloon which inflates once inside the breast (Mammosite™).
A radioactive pellet is inserted into the catheter(s) twice daily for
5 days via an HDR afterloading machine, then the catheters are removed.
Multicatheter
brachytherapy involves placing several catheters into the breast, usually
10 - 20, although the number may vary. This is the longest researched
method of APBI in the US. It offers great flexibility and is potentially
the most targeted APBI treatment. It is also the most technical to
perform, and perhaps not as reproducible between different cancer centers.
The
Mammosite device uses a single thicker catheter which enters into a
cavity inside the breast where the tumor used to be. A ballon is then
inflated to a diameter of about 2 inches, which entirely fills the
cavity. This procedure is more reproducible between different cancer
centers. Not everyone can have the mammosite however -- it should be
done within 6 weeks of surgery and there should be a cavity (seroma)
still present in the breast whish is not too big, not too small, and
not too close to the skin surface.
Who Can have APBI?
Women with small early breast cancers are typically eligible for APBI.
There is still uncertainty about who it is best for, and when there
is doubt your doctor may recommend standard radiation methods. Generally
you need a small tumor, with clear surgical margins after lumpectomy,
and preferably no lymph nodes containing cancer. Here are a list of
criteria for APBI.
| Criteria |
Good |
Medium |
Bad |
| Tumor Size |
0 - 2.5 cm |
2.5 - 4 cm |
4 cm or more |
| Age |
Over 50
Post-menopausal |
40/45 to 50
Pre-menopausal |
Under 40/45 |
ER-PR
Receptors |
Positive |
Negative |
|
| Timing |
Before chemo |
After chemo |
|
| Nodes Positive |
None |
One microscopic |
More than one |
| Pathology |
Invasive ductal &
Neg.Margins
|
Invasive Lobular,
DCIS, Multifocal,
Lymphatic invasion |
EIC+ Multicentric |
Results
APBI is a new concept, and there are good 5 - 10 year results available
for multicatheter brachytherapy APBI. Not all doctors believe in it.
There is a large ongoing multihospital randomized study underway (RTOG
0413) to try to answer the question of whether APBI is an acceptable
option to regular whole
breast
external
beam radiation. Certainly, selecting the right women for this treatment
and doing a good treatment technique are vital to having good results.
For mammosite, a William Beaumont Hosp study showed
a 3% rate of cancer recurrence in the breast within the first 3 years.
This would be similiar to what is
seen after external beam radiation to the whole breast. Cosmetic appearance
was good/excellent in 88% at the 3 year mark.
A study from
Hungary in 2007 randomly compared women to receive either 1)APBI with
multicatheter brachytherapy, 2)APBI with electron external beam radiation,
or 3)standard
whole breast radiation. There was no statistical difference in the
5 year rate of cancer recurrence in the breast, which was 3.4 - 4.7%.
The brachytherapy patients had the best cosmetic appearance of the
breast afterwards.
|